Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.36
Delayed Data
As of Feb 16
 -0.02 / -1.45%
Today’s Change
1.06
Today|||52-Week Range
2.12
-1.45%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close1.38
Today’s open1.38
Day’s range1.36 - 1.39
Volume49,129
Average volume (3 months)459,532
Market cap$149.7M
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-10.34%
Earnings growth (this year)-7.29%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.36

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...0.000.00%
EVGNEvogene Ltd-0.07-1.83%
AXSMAxsome Therapeutics ...+0.10+3.85%
KDMNKadmon Holdings Inc-0.02-0.55%
Data as of 4:02pm ET, 02/16/2018

Financials

Last reporting dateFebruary 7, 2018
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$27.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Co-Chief Executive Officer
Zami Aberman
President, Co-Chief Executive Officer &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts